OrbiMed’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-62,121
| Closed | -$250K | – | 135 |
|
|
2023
Q3 | $250K | Sell |
62,121
-1
| -0% | -$4 | 0.01% | 119 |
|
|
2023
Q2 | $441K | Hold |
62,122
| – | – | 0.01% | 118 |
|
|
2023
Q1 | $462K | Sell |
62,122
-89,528
| -59% | -$666K | 0.01% | 115 |
|
|
2022
Q4 | $1.1M | Sell |
151,650
-150,941
| -50% | -$1.1M | 0.02% | 107 |
|
|
2022
Q3 | $2.94K | Sell |
302,591
-1,360
| -0.4% | -$13 | 0.05% | 113 |
|
|
2022
Q2 | $5.81K | Hold |
303,951
| – | – | 0.11% | 107 |
|
|
2022
Q1 | $15.1M | Buy |
303,951
+13,600
| +5% | +$676K | 0.24% | 79 |
|
|
2021
Q4 | $21.9M | Buy |
290,351
+29,220
| +11% | +$2.21M | 0.28% | 82 |
|
|
2021
Q3 | $20.6M | Hold |
261,131
| – | – | 0.23% | 95 |
|
|
2021
Q2 | $36.2M | Buy |
261,131
+32,561
| +14% | +$4.52M | 0.37% | 72 |
|
|
2021
Q1 | $47.8M | Buy |
228,570
+45,000
| +25% | +$9.41M | 0.45% | 63 |
|
|
2020
Q4 | $30.5M | Hold |
183,570
| – | – | 0.27% | 83 |
|
|
2020
Q3 | $31.2M | Hold |
183,570
| – | – | 0.39% | 69 |
|
|
2020
Q2 | $30.5M | Sell |
183,570
-61,071
| -25% | -$10.1M | 0.43% | 64 |
|
|
2020
Q1 | $28.3M | Hold |
244,641
| – | – | 0.48% | 56 |
|
|
2019
Q4 | $36.2M | Hold |
244,641
| – | – | 0.52% | 54 |
|
|
2019
Q3 | $33.4M | Hold |
244,641
| – | – | 0.63% | 47 |
|
|
2019
Q2 | $31.8M | Hold |
244,641
| – | – | 0.49% | 51 |
|
|
2019
Q1 | $23.2M | Buy |
+244,641
| New | +$23.2M | 0.36% | 67 |
|